Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin-Reference-Cited by-同舟云学术

Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin

Published:2015-10 Issue:42 Volume:94 Page:e1756
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Ogata Hideaki,Kikuchi Yoshihiro,Natori Kazuhiko,Shiraga Nobuyuki,Kobayashi Masahiro,Magoshi Shunsuke,Saito Fumi,Osaku Tadatoshi,Kanazawa Shinsaku,Kubota Yorichika,Murakami Yoshie,Kaneko Hironori

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference25 articles.

1. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.;Tischkowitz;BMC Cancer,2007

2. The paradox of triple negative breast cancer: novel approaches to treatment.;Fornier;Breast J,2012

3. Emerging targeted therapies in triple-negative breast cancer.;Crown;Ann Oncol,2012

4. Prevalence of BRCA1 mutations in triple negative breast cancer (BC).;Kandel;J Clin Oncol,2006

5. The role of BRCA1 in the cellular response to chemotherapy.;Kennedy;J Natl Cancer Inst,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the metastatic mechanism and progress in the treatment of breast cancer liver metastasis: a narrative review;Translational Cancer Research;2023-06

2. Orthotopic and heterotopic triple negative breast cancer preclinical murine models: A tumor microenvironment comparative;Research in Veterinary Science;2022-12

3. A case report of the sustained and rapid response of bevacizumab in a TP53-positive breast cancer and liver metastatic patient through personalized medicine;Frontiers in Oncology;2022-09-02

4. Efficacy and safety of taxanes combined with chemotherapy drugs in advanced triple negative breast cancer: A meta-analysis of 26 randomized controlled trials;Frontiers in Oncology;2022-08-31

5. Chimiothérapie du cancer du sein au cours de la grossesse: à propos d´un cas;Pan African Medical Journal;2021